92 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
1 Unknown  Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Conditions: Endometrial Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Leiomyoma
Intervention:
2 Recruiting Robotic Versus Abdominal Surgery for Endometrial Cancer
Condition: Endometrial Neoplasms
Interventions: Procedure: Robotic surgery;   Procedure: Abdominal surgery
3 Not yet recruiting Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma
Condition: Endometrial Neoplasms
Intervention: Drug: Ponatinib
4 Recruiting STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms
Interventions: Procedure: Transperitoneal laparoscopic aortic lymphadenectomy;   Procedure: Extraperitoneal laparoscopic aortic lymphadenectomy
5 Recruiting The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma
Condition: Endometrial Neoplasms
Interventions: Drug: Paclitaxel;   Drug: Paraplatin (Carboplatin Injection);   Radiation: Pelvic Radiation;   Radiation: Vaginal Brachytherapy 1;   Radiation: Vaginal brachytherapy 2
6 Unknown  Early Detection of Cancers in Low Resource Countries
Conditions: Breast Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Endometrial Neoplasms
Interventions: Procedure: Breast Cancer Screening and Diagnosis;   Procedure: Cervical Cancer Screening and Diagnosis;   Procedure: Ovarian Cancer Screening and Diagnosis;   Procedure: Endometrial Cancer Screening and Diagnosis
7 Recruiting [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
Conditions: Uterine Cervical Neoplasms;   Endometrial Neoplasms;   Anus Neoplasms;   Rectal Neoplasms;   Prostatic Neoplasms
Intervention: Radiation: Bone marrow sparing IMRT radiation therapy
8 Unknown  Questionnaire Study for Gynecological Cancer Survivors
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms;   Uterine Cervical Neoplasms;   Vulvar Neoplasms;   Vaginal Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: Psychosocial
9 Recruiting Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
Conditions: Menorrhagia;   Endometrial Neoplasms;   Polycystic Ovary Syndrome;   Uterine Neoplasms
Interventions: Device: SonoBiopsy Catheter;   Device: Endometrial biopsy catheter
10 Recruiting The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma
Condition: Endometrial Neoplasms
Interventions: Procedure: TH;   Procedure: TH/BSO;   Procedure: BPLND
11 Recruiting Molecular Markers in Treatment in Endometrial Cancer
Conditions: Endometrial Neoplasms;   Neoplasm Metastasis
Intervention: Procedure: Tumor biopsy study
12 Recruiting Lymph Node Mapping in Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: sentinel lymph node detection;   Drug: indocyanine green solution;   Drug: isosulfan blue;   Procedure: sentinel lymph node biopsy
13 Not yet recruiting A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
Condition: Endometrial Cancer
Intervention: Drug: BMN 673
14 Recruiting Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Conditions: Lymphedema;   Stage IA Cervical Cancer;   Stage IA Endometrial Carcinoma;   Stage IA Vulvar Cancer;   Stage IB Cervical Cancer;   Stage IB Endometrial Carcinoma;   Stage IB Vulvar Cancer;   Stage II Endometrial Carcinoma;   Stage II Vulvar Cancer;   Stage IIA Cervical Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVB Vulvar Cancer
Interventions: Procedure: therapeutic lymphadenectomy;   Procedure: therapeutic conventional surgery;   Procedure: therapeutic laparoscopic surgery;   Procedure: study of high risk factors;   Other: questionnaire administration;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
15 Recruiting Intravenous Paclitaxel and Intraperitoneal Carboplatin Followed By Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
Conditions: Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IIIA Endometrial Carcinoma;   Stage IIIB Endometrial Carcinoma;   Stage IIIC Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
16 Recruiting Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery
Condition: Early Stage Endometrial Cancer
Interventions: Procedure: Upper vaginectomy;   Radiation: Post-operative brachytherapy;   Procedure: Standard procedures
17 Recruiting Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery
Condition: Endometrial Cancer
Intervention: Procedure: Fluorescence-guided sentinel lymph node detection
18 Recruiting A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
Condition: Endometrial Cancer
Intervention: Drug: Fluorescein
19 Recruiting MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Recurrent Adult Brain Tumor;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: TORC1/2 inhibitor MLN0128;   Biological: bevacizumab;   Other: pharmacological study;   Other: laboratory biomarker analysis
20 Recruiting Accuracy of Sentinel Lymph Node Biopsy and Gadofosveset-Enhanced MR in Nodal Staging of High Risk Endometrial Cancer
Conditions: High Grade Endometrial Cancer;   Sentinel Lymph Node Mapping;   Ablavar
Intervention: Biological: Gadofosveset Trisodium (Ablavar)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years